Skip to Content


Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.


Final rule; correction.


The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 8, 2002 (67 FR 5942). The document amended the final monograph for over-the-counter (OTC) topical antifungal drug products to add the ingredient clotrimazole as generally recognized as safe and effective for the treatment of athlete's foot, jock itch, and ringworm. The document was inadvertently published with an incorrect docket number. This document corrects that error.

Start Further Info


Doris B. Tucker, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.

In FR Doc. 02-3079, appearing on page 5942 in the Federal Register of Friday, February 8, 2002, the following correction is made:

1. On page 5942, in the first column, “[Docket No. 99N-4063]” is corrected to read “[Docket No. 96P-0460]”.

Start Signature

Dated: March 7, 2002.

Margaret M. Dotzel,

Associate Commissioner for Policy.

End Signature End Further Info End Preamble

[FR Doc. 02-6180 Filed 3-14-02; 8:45 am]